Berria R - Search Results

1

Lixisenatide as add-on treatment among patients with different β-cell function levels as assessed by HOMA-β index.

Bonadonna RC, Blonde L, Antsiferov M, Berria R, Gourdy P, Hatunic M, Mohan V, Horowitz M. Bonadonna RC, et al. Among authors: berria r. Diabetes Metab Res Rev. 2017 Sep;33(6):e2897. doi: 10.1002/dmrr.2897. Epub 2017 Jun 20. Diabetes Metab Res Rev. 2017. PMID: 28303626 Free PMC article.

2

Pronounced reduction of postprandial glucagon by lixisenatide: a meta-analysis of randomized clinical trials.

Ahrén B, Gautier JF, Berria R, Stager W, Aronson R, Bailey CJ. Ahrén B, et al. Among authors: berria r. Diabetes Obes Metab. 2014 Sep;16(9):861-8. doi: 10.1111/dom.12290. Epub 2014 Apr 11. Diabetes Obes Metab. 2014. PMID: 24641271

3

Weight loss, glycemic control, and changes in cardiovascular biomarkers in patients with type 2 diabetes receiving incretin therapies or insulin in a large cohort database.

Horton ES, Silberman C, Davis KL, Berria R. Horton ES, et al. Among authors: berria r. Diabetes Care. 2010 Aug;33(8):1759-65. doi: 10.2337/dc09-2062. Epub 2010 May 11. Diabetes Care. 2010. PMID: 20460445 Free PMC article.

4

Lixisenatide treatment for older patients with type 2 diabetes mellitus uncontrolled on oral antidiabetics: meta-analysis of five randomized controlled trials.

Hanefeld M, Berria R, Lin J, Aronson R, Darmon P, Evans M, Van Gaal L. Hanefeld M, et al. Among authors: berria r. Adv Ther. 2014 Aug;31(8):861-72. doi: 10.1007/s12325-014-0146-4. Epub 2014 Aug 21. Adv Ther. 2014. PMID: 25143188

5

Free fatty acids reduce splanchnic and peripheral glucose uptake in patients with type 2 diabetes.

Bajaj M, Pratipanawatr T, Berria R, Pratipanawatr W, Kashyap S, Cusi K, Mandarino L, DeFronzo RA. Bajaj M, et al. Among authors: berria r. Diabetes. 2002 Oct;51(10):3043-8. doi: 10.2337/diabetes.51.10.3043. Diabetes. 2002. PMID: 12351445 Clinical Trial.

6

A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes.

Kashyap S, Belfort R, Gastaldelli A, Pratipanawatr T, Berria R, Pratipanawatr W, Bajaj M, Mandarino L, DeFronzo R, Cusi K. Kashyap S, et al. Among authors: berria r. Diabetes. 2003 Oct;52(10):2461-74. doi: 10.2337/diabetes.52.10.2461. Diabetes. 2003. PMID: 14514628 Clinical Trial.

7

Reduced skeletal muscle inhibitor of kappaB beta content is associated with insulin resistance in subjects with type 2 diabetes: reversal by exercise training.

Sriwijitkamol A, Christ-Roberts C, Berria R, Eagan P, Pratipanawatr T, DeFronzo RA, Mandarino LJ, Musi N. Sriwijitkamol A, et al. Among authors: berria r. Diabetes. 2006 Mar;55(3):760-7. doi: 10.2337/diabetes.55.03.06.db05-0677. Diabetes. 2006. PMID: 16505240

8

Treatment with the human once-weekly glucagon-like peptide-1 analog taspoglutide in combination with metformin improves glycemic control and lowers body weight in patients with type 2 diabetes inadequately controlled with metformin alone: a double-blind placebo-controlled study.

Nauck MA, Ratner RE, Kapitza C, Berria R, Boldrin M, Balena R. Nauck MA, et al. Among authors: berria r. Diabetes Care. 2009 Jul;32(7):1237-43. doi: 10.2337/dc08-1961. Epub 2009 Apr 14. Diabetes Care. 2009. PMID: 19366970 Free PMC article. Clinical Trial.

9

Achieving postprandial glucose control with lixisenatide improves glycemic control in patients with type 2 diabetes on basal insulin: a post-hoc analysis of pooled data.

Davidson JA, Stager W, Paranjape S, Berria R, Leiter LA. Davidson JA, et al. Among authors: berria r. Clin Diabetes Endocrinol. 2020 Jan 14;6:2. doi: 10.1186/s40842-019-0088-5. eCollection 2020. Clin Diabetes Endocrinol. 2020. PMID: 31956422 Free PMC article.

10

Skeletal muscle insulin resistance in normoglycemic subjects with a strong family history of type 2 diabetes is associated with decreased insulin-stimulated insulin receptor substrate-1 tyrosine phosphorylation.

Pratipanawatr W, Pratipanawatr T, Cusi K, Berria R, Adams JM, Jenkinson CP, Maezono K, DeFronzo RA, Mandarino LJ. Pratipanawatr W, et al. Among authors: berria r. Diabetes. 2001 Nov;50(11):2572-8. doi: 10.2337/diabetes.50.11.2572. Diabetes. 2001. PMID: 11679436

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

41 results

Search Page